Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report)’s stock price fell 2% on Thursday . The stock traded as low as $1.96 and last traded at $2.00. 23,750 shares traded hands during mid-day trading, an increase of 54% from the average session volume of 15,455 shares. The stock had previously closed at $2.04.
Medexus Pharmaceuticals Stock Up 5.5%
The firm’s 50 day simple moving average is $2.03 and its 200 day simple moving average is $2.03.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals, Inc is a specialty pharmaceutical company headquartered in Mississauga, Ontario. The company focuses on acquiring, developing and commercializing niche prescription drug products for markets in Canada and the United States. Its efforts are aimed at underserved therapeutic areas, including rare diseases, oncology, hematology and dermatology.
Through strategic licensing and partnership agreements with international pharmaceutical firms, Medexus sources late‐stage and marketed assets, then manages their regulatory approval and commercialization.
Read More
- Five stocks we like better than Medexus Pharmaceuticals
- Think You Missed Silver? You’re Wrong. Here’s Why.
- Your Bank Account Is No Longer Safe
- [Revealed] The $100 Starlink Pre-IPO Jackpot!
- What a Former CIA Agent Knows About the Coming Collapse
- Nvidia CEO Issues Bold Tesla Call
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
